Evidence map›Paper›PMID 32503985›Full record

ReviewNPJ primary care respiratory medicine2020

Bringing asthma care into the twenty-first century.

Kjell Larsson, Hannu Kankaanranta, Christer Janson, Lauri Lehtimäki, Björn Ställberg, Anders Løkke, Kristian Høines, Klaus Roslind, Charlotte Suppli Ulrik

Open access · goldAbstract readReview
In one paragraph

Review in NPJ primary care respiratory medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 51 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Novel insights into asthma pathophysiology and pharmacological interventions: spiral of respiratory symptoms and psychiatric episodes.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2025
    Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Asthma and COPD: A Focus on β-Agonists - Past, Present and Future.Handbook of experimental pharmacology · 2024
    Review
  13. Cytotoxic CD4Med (New York, N.Y.) · 2023
    Article
  14. Review
  15. Review
  16. Article
  17. Pharmacometabolomics of Asthma as a Road Map to Precision Medicine.Handbook of experimental pharmacology · 2023
    Article
  18. Article
  19. Observational
  20. Study on Allopathic and Alternative Treatments of Asthma and Factors Influencing Treatment Choices.Evidence-based complementary and alternative medicine : eCAM · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 4 countries.

Kjell LarssonIntegrative Toxicology, National Institute of Environmental Medicine, IMM, Karolinska Institute, Stockholm, Sweden. kjell.larsson@ki.se.
Hannu KankaanrantaDepartment of Respiratory Medicine, Seinäjoki Central Hospital, Seinäjoki, Finland.ORCID http://orcid.org/0000-0001-5258-0906
Christer JansonDepartment of Medical Sciences: Respiratory, Allergy and Sleep Research, Uppsala University, Uppsala, Sweden.
Lauri LehtimäkiFaculty of Medicine and Health Technology, University of Tampere, Tampere, Finland.ORCID http://orcid.org/0000-0003-1586-4998
Björn StällbergDepartment of Public Health and Caring Sciences, Family Medicine and Preventive Medicine, Uppsala University, Uppsala, Sweden.
Anders LøkkeDepartment of Medicine, Little Belt Hospital, Vejle, Denmark.ORCID http://orcid.org/0000-0002-6905-4141
Kristian HøinesTananger Medical Center, Tananger, Norway.
Klaus RoslindAarup Doctors Medical Centre, Aarup, Denmark.
Charlotte Suppli UlrikRespiratory Research Unit Hvidovre, Department of Respiratory Medicine, Copenhagen University Hospital Hvidovre, Hvidovre, Denmark.
Tampere University · FIUppsala University · SEKarolinska Institutet · SELevanger Hospital · NOUniversity of Copenhagen · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite access to diagnostic tests and effective therapies, asthma often remains misdiagnosed and/or poorly controlled or uncontrolled. In this review, we address the key issues of asthma diagnosis and management, recent evidence for levels of asthma control, the consequences of poor control and, in line with that, explore the potential reasons for poor asthma control and acute exacerbations. Based on recent evidence and current guidelines, we also aim to provide practical answers to the key questions of how to improve asthma management, with the best possible prevention of exacerbations, addressing the basics-adherence, inhaler misuse, obesity and smoking-and how to facilitate a new era of asthma care in the twenty-first century. We hope this review will be useful to busy primary care clinicians in their future interactions with their patients with both suspected and proven asthma.

Indexed as

Anti-Asthmatic AgentsAsthmaDelivery of Health CareForecastingHumansPatient Care PlanningPatient ComplianceAnti-Asthmatic Agents

Identifiers

PMID32503985
PMCPMC7275071
OpenAlexW3033875171

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.